JP2018500325A - 前駆細胞を用いた網膜変性の治療法 - Google Patents

前駆細胞を用いた網膜変性の治療法 Download PDF

Info

Publication number
JP2018500325A
JP2018500325A JP2017532063A JP2017532063A JP2018500325A JP 2018500325 A JP2018500325 A JP 2018500325A JP 2017532063 A JP2017532063 A JP 2017532063A JP 2017532063 A JP2017532063 A JP 2017532063A JP 2018500325 A JP2018500325 A JP 2018500325A
Authority
JP
Japan
Prior art keywords
cells
cell
rpe
hutc
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017532063A
Other languages
English (en)
Japanese (ja)
Inventor
ハリス，イアン
カオ，ジン
デネカ，ナディーン，ソフィア
Original Assignee
ヤンセン バイオテツク，インコーポレーテツド
ヤンセン バイオテツク，インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヤンセン バイオテツク，インコーポレーテツド, ヤンセン バイオテツク，インコーポレーテツド filed Critical ヤンセン バイオテツク，インコーポレーテツド
Publication of JP2018500325A publication Critical patent/JP2018500325A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2017532063A 2014-12-16 2015-12-04 前駆細胞を用いた網膜変性の治療法 Pending JP2018500325A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462092658P 2014-12-16 2014-12-16
US62/092,658 2014-12-16
US201562236732P 2015-10-02 2015-10-02
US62/236,732 2015-10-02
PCT/US2015/063931 WO2016099949A2 (en) 2014-12-16 2015-12-04 Treatment of retinal degeneration using progenitor cells

Publications (1)

Publication Number Publication Date
JP2018500325A true JP2018500325A (ja) 2018-01-11

Family

ID=56110114

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017532063A Pending JP2018500325A (ja) 2014-12-16 2015-12-04 前駆細胞を用いた網膜変性の治療法

Country Status (15)

Country Link
US (1) US20160166619A1 (cg-RX-API-DMAC10.html)
EP (1) EP3233096A4 (cg-RX-API-DMAC10.html)
JP (1) JP2018500325A (cg-RX-API-DMAC10.html)
KR (1) KR20170094368A (cg-RX-API-DMAC10.html)
CN (1) CN107249608A (cg-RX-API-DMAC10.html)
AU (1) AU2015363088A1 (cg-RX-API-DMAC10.html)
BR (1) BR112017012581A2 (cg-RX-API-DMAC10.html)
CA (1) CA2970641A1 (cg-RX-API-DMAC10.html)
MX (1) MX2017007953A (cg-RX-API-DMAC10.html)
PH (1) PH12017501028A1 (cg-RX-API-DMAC10.html)
RU (1) RU2017124983A (cg-RX-API-DMAC10.html)
SG (1) SG11201704668PA (cg-RX-API-DMAC10.html)
TW (1) TW201632620A (cg-RX-API-DMAC10.html)
WO (1) WO2016099949A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA201704793B (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
MX2018006729A (es) * 2015-12-04 2018-11-09 Janssen Biotech Inc Tratamiento de la degeneracion de la retina mediante el uso de celulas progenitoras.
JP6799248B2 (ja) * 2016-09-28 2020-12-16 澁谷工業株式会社 細胞シートの切断方法
WO2018102174A1 (en) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
GB201703058D0 (en) 2017-02-24 2017-04-12 Ucl Business Plc Biomarkers
KR102091567B1 (ko) * 2018-06-15 2020-03-20 인하대학교 산학협력단 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물
CN109456937A (zh) * 2018-12-27 2019-03-12 广州赛莱拉干细胞科技股份有限公司 一种制备子宫内膜干细胞的培养基以及制备方法
US10758571B1 (en) 2019-04-09 2020-09-01 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome
WO2021207282A2 (en) 2020-04-07 2021-10-14 Combangio, Inc. Lyophilized mesenchymal stem cell derived secretome and uses thereof
CN115998845B (zh) * 2020-10-26 2026-04-10 上海交通大学医学院附属第九人民医院 血小板反应蛋白1在制备预防和/或治疗视网膜损伤的药物中的应用
CN115177717B (zh) * 2022-08-31 2026-02-06 贵州医科大学附属医院 一种治疗眼表及角膜上皮疾病的药物
CN117004554B (zh) * 2023-08-09 2026-01-06 北京燕麝生物科技发展有限公司 一种林麝香腺细胞的培养基及林麝香腺细胞的培养方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100272803A1 (en) * 2003-06-27 2010-10-28 Sanjay Mistry Repair and regeneration of ocular tissue using postpartum-derived cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2569780T3 (es) * 2003-06-27 2016-05-12 DePuy Synthes Products, Inc. Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
US9572840B2 (en) * 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100272803A1 (en) * 2003-06-27 2010-10-28 Sanjay Mistry Repair and regeneration of ocular tissue using postpartum-derived cells

Also Published As

Publication number Publication date
BR112017012581A2 (pt) 2017-12-26
CN107249608A (zh) 2017-10-13
PH12017501028A1 (en) 2018-03-05
US20160166619A1 (en) 2016-06-16
WO2016099949A2 (en) 2016-06-23
ZA201704793B (en) 2019-01-30
TW201632620A (zh) 2016-09-16
RU2017124983A3 (cg-RX-API-DMAC10.html) 2019-06-05
EP3233096A2 (en) 2017-10-25
KR20170094368A (ko) 2017-08-17
SG11201704668PA (en) 2017-07-28
EP3233096A4 (en) 2018-08-22
CA2970641A1 (en) 2016-06-23
MX2017007953A (es) 2018-02-09
AU2015363088A1 (en) 2017-06-15
RU2017124983A (ru) 2019-01-17

Similar Documents

Publication Publication Date Title
EP1641915B1 (en) Repair and regeneration of ocular tissue using postpartum-derived cells
JP6000982B2 (ja) 臍由来細胞を使用する筋萎縮性側索硬化症の治療
US20150064781A1 (en) Repair and regeneration of ocular tissue using postpartum-derived cells
US20160166619A1 (en) Treatment of Retinal Degeneration Using Progenitor Cells
US20180344777A1 (en) Method of modulating müller glia cells
US20170080033A1 (en) Treatment of retinal degeneration using progenitor cells
US20180327713A1 (en) Treatment of retinal degeneration using progenitor cells
US20160158293A1 (en) Treatment of Ocular Conditions Using Progenitor Cells
WO2018102174A1 (en) Treatment of retinal degeneration using progenitor cells
US20180015129A1 (en) Treatment of retinal vascular disease using progenitor cells
US20170157179A1 (en) Treatment of retinal degeneration using progenitor cells

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20181203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191203

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200630